# Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial

> **NCT03508830** · PHASE3 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 91 (actual)

## Conditions studied

- Thoracic Diseases
- Postoperative Pain
- Opioid Use

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine Injection

## Key facts

- **NCT ID:** NCT03508830
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-30
- **Primary completion:** 2021-01-30
- **Final completion:** 2021-01-30
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03508830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03508830, "Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03508830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*